15 completed, 3 terminated, 2 unknown, 2 withdrawn. 6 Phase 3, 4 Not applicable, 4 Phase 2, 4 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 1, Unknown 1 |
| Not applicable | 4 | Completed 3, Terminated 1 |
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Phase 4 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow MultiHance: new trials by email Literature Review of MultiHance trials Research Report on MultiHance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics Gadopiclenol, Gadobenate dimeglumine - Congenital Heart Disease | Phase 3 | Unknown | University of California, San Diego | 160 | 2024-05-01 | 2024-05-09 |
| PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol - Prostate Carcinoma | Phase 2 | Withdrawn | Northwestern University | 2023-06-17 | 2025-10-21 | |
| Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases Gadoxetate disodium, Gadobenate dimeglumine - Oligometastatic Disease, Liver Metastases | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2021-06-22 | 2026-09-25 |
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function | Phase 4 | Recruiting | Guerbet | 2076 | 2021-03-24 | 2026-01-22 |
| Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions Gadobenate Dimeglumine, Gadobutrol, Magnetic Resonance Imaging - Brain Neoplasm, Lymphoma | Not applicable | Completed | M.D. Anderson Cancer Center | 6 | 2020-01-10 | 2022-11-21 |
| Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS (18F)FES, Gadobenate dimeglumine - Breast Cancer, Ductal Carcinoma in Situ - Category | Phase 2 | Completed | University of Wisconsin, Madison | 12 | 2019-01-03 | 2025-02-12 |
| Whole-Heart Myocardial Blood Flow Quantification Using MRI Myocardial Perfusion Cardiac MRI., Contrast, Pharmacologic Stress Agent - Coronary Artery Disease, Coronary Microvascular Disease | Unknown | Cedars-Sinai Medical Center | 160 | 2018-03-01 | 2023-02-08 | |
| Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients MultiHance - Central Nervous System Diseases, Central Nervous System Neoplasms | Completed | Bracco Diagnostics, Inc | 352 | 2017-05-18 | 2018-07-18 | |
| QSM and Regional DCE MRI Permeability Using GOCART Technique Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Gadobenate Dimeglumine, Gadoterate Meglumine - Intracranial Neoplasm | Withdrawn | University of Southern California | 2017-04-04 | 2021-04-05 | ||
| P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) P03277, Gadobenate dimeglumine, MRI - CNS Lesion, Blood Brain Barrier Defect | Phase 2 | Completed | Guerbet | 312 | 2016-06-01 | 2021-10-25 |
| Retrospective Study of MRI in Pediatric Patients Gadobenate Dimeglumine - Central Nervous System Disease, Central Nervous System Neoplasms | Completed | Bracco Diagnostics, Inc | 90 | 2014-11-01 | 2016-07-19 | |
| Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients Regadenoson MRI, Gadobenate dimeglumine - Atrial Fibrillation, Coronary Artery Disease | Phase 2 | Completed | University of Utah | 30 | 2013-01-01 | 2017-12-13 |
| Identification of Adverse Plaque Characteristics by Coronary MR Angiography Coronary MR Angiography (CMRA) - Coronary Artery Disease | Not applicable | Completed | Cedars-Sinai Medical Center | 2 | 2012-04-01 | 2021-01-27 |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Gadobenate Dimeglumine, Gadobutrol - Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma | Not applicable | Terminated | University of Southern California | 14 | 2011-12-14 | 2017-03-27 |
| Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries Gadobenate Dimeglumine, Gadopentetate Dimeglumine - Carotid, Aortic, Renal or Peripheral Artery Disease | Phase 3 | Completed | Bracco Diagnostics, Inc | 120 | 2009-09-01 | 2012-01-05 |
| Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. gadobenate dimeglumine (MultiHance) - Hepatocellular Carcinoma | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 45 | 2007-09-01 | 2017-09-26 |
| Multihance Versus Magnevist in Breast MRI Multihance, Magnevist - Breast Cancer | Phase 3 | Completed | Bracco Diagnostics, Inc | 130 | 2007-07-01 | 2010-07-15 |
| Crossover Study With MultiHance vs a Comparator for Peripheral MRA MultiHance, Magnevist - Peripheral Vascular Disease | Phase 3 | Completed | Bracco Diagnostics, Inc | 100 | 2006-12-01 | 2009-03-27 |
| Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent Multihance, vasovist - Steno-occlusive Disease | Phase 3 | Completed | Bracco Diagnostics, Inc | 39 | 2006-12-01 | 2023-08-01 |
| Multihance at 3 Tesla (3T) in Brain Tumors Multihance, Arm 2 - Magnevist - Brain Tumor | Phase 4 | Completed | Bracco Diagnostics, Inc | 46 | 2006-11-01 | 2020-11-05 |
Showing 20 of 23. Sign in to see all of them.
Brain Neoplasms (4) · Breast Neoplasms (3) · Central Nervous System Diseases (3) · Coronary Artery Disease (3) · Carcinoma, Hepatocellular (2) · Central Nervous System Neoplasms (2) · Colorectal Neoplasms (2) · Prostatic Neoplasms (2) · Astrocytoma (1) · Atrial Fibrillation (1) · Choroid Plexus Neoplasms (1) · Ependymoma (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1)
Bracco Diagnostics, Inc (10) · Cedars-Sinai Medical Center (2) · Guerbet (2) · University of Southern California (2) · M.D. Anderson Cancer Center (1) · Northwestern University (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of California, San Diego (1) · University of Colorado, Denver (1) · University of Utah (1) · University of Wisconsin, Madison (1)
United States (17) · Italy (5) · Poland (2) · South Korea (2) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Mexico (1) · Russia (1)
Gianpaolo Pirovano, MD (3) · Gianpaolo Priovano, M.D. (2) · Albert Hsiao, MD/PhD (1) · Alexander Lerner (1) · Amy Fowler (1) · Barry Hogstrom, M. D. (1) · Brent Wilson, MD (1) · Daniel S Berman, MD (1) · Edward M Schaeffer, MD/PhD (1) · Gianpaolo Pirovano, M. D. (1) · Gianpaolo Pirovano, M.D. (1) · Gianpaolo Priovano, MD (1) · Ihab Kamel (1) · Ken-Pin Hwang, MD (1)
PMID 19306364, PMID 21163915, PMID 23042922, PMID 28528431
P30CA014089 (2), KL2TR000428 (1), P30CA014520 (1), P30CA046934 (1), P30CA060553 (1), R01HL124649 (1)